Hallemeesch M M, Lamers W H, Soeters P B, Deutz N E
Department of Surgery, Maastricht University, 6200 MD Maastricht, The Netherlands.
Am J Physiol Gastrointest Liver Physiol. 2000 Jan;278(1):G83-8. doi: 10.1152/ajpgi.2000.278.1.G83.
Noninvasive assessment of intestinal permeability in vivo is based on the measurement of urinary excretion of orally administered sugar probes. It is expressed as a ratio, usually lactulose/rhamnose or 3-O-methyl-D-glucose (3-OMG)/rhamnose. In both endotoxemic and control rats that were receiving fluid, we observed an increase in the recovery of lactulose and 3-OMG but not rhamnose in both groups, suggesting an enhancement of intestinal permeability. In the measurement of intestinal permeability, all pre- and postmucosal factors are considered equal for all sugars. We hypothesized that postmucosal factors and not changes in intestinal permeability caused the increased urinary lactulose and 3-OMG recoveries observed during fluid loading. Therefore, the effects of fluid loading on urinary excretion of the sugar probes were studied in healthy rats receiving the sugars intravenously. After intravenous injection, fluid loading increased urinary lactulose recovery threefold but not that of 3-OMG and rhamnose. In conclusion, fluid loading increases the lactulose/rhamnose ratio independent of changes in intestinal permeability. The 3-OMG/rhamnose ratio is not influenced by fluid loading.
体内肠道通透性的无创评估基于口服糖探针后尿排泄量的测定。它以比率表示,通常是乳果糖/鼠李糖或3 - O - 甲基 - D - 葡萄糖(3 - OMG)/鼠李糖。在接受补液的内毒素血症大鼠和对照大鼠中,我们观察到两组中乳果糖和3 - OMG的回收率均增加,但鼠李糖的回收率未增加,这表明肠道通透性增强。在肠道通透性测量中,所有糖的黏膜前和黏膜后因素都被认为是相等的。我们推测,黏膜后因素而非肠道通透性的变化导致了补液期间观察到的尿乳果糖和3 - OMG回收率增加。因此,在静脉注射糖的健康大鼠中研究了补液对糖探针尿排泄的影响。静脉注射后,补液使尿乳果糖回收率增加了三倍,但3 - OMG和鼠李糖的回收率未增加。总之,补液增加了乳果糖/鼠李糖比率,而与肠道通透性的变化无关。3 - OMG/鼠李糖比率不受补液影响。